Literature DB >> 28008791

Adapting censored regression methods to adjust for the limit of detection in the calibration of diagnostic rules for clinical mass spectrometry proteomic data.

Alexia Kakourou1, Werner Vach2, Bart Mertens1.   

Abstract

In this paper, we consider the problem of calibrating diagnostic rules based on high-resolution mass spectrometry data subject to the limit of detection. The limit of detection is related to the limitation of instruments in measuring low-concentration proteins. As a consequence, peak intensities below the limit of detection are often reported as missing during the quantification step of proteomic analysis. We propose the use of censored data methodology to handle spectral measurements within the presence of limit of detection, recognizing that those have been left-censored for low-abundance proteins. We replace the set of incomplete spectral measurements with estimates of the expected intensity and use those as input to a prediction model. To correct for lack of information and measurement uncertainty, we combine this approach with borrowing of information through the addition of an individual-specific random effect formulation. We present different modalities of using the above formulation for prediction purposes and show how it may also allow for variable selection. We evaluate the proposed methods by comparing their predictive performance with the one achieved using the complete information as well as alternative methods to deal with the limit of detection.

Keywords:  Clinical mass spectrometry-based proteomics; borrowing of information; censored regression; limit of detection; prediction; variable selection

Mesh:

Year:  2016        PMID: 28008791     DOI: 10.1177/0962280216685742

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  1 in total

1.  Statistical tests for latent class in censored data due to detection limit.

Authors:  Hua He; Wan Tang; Tanika Kelly; Shengxu Li; Jiang He
Journal:  Stat Methods Med Res       Date:  2019-11-18       Impact factor: 3.021

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.